Dr Agarwal’s Healthcare allotment today: How to check allotment status online on BSE, NSE, KFin Technologies

Dr Agarwal’s Healthcare, recently concluded its IPO. The company’s public issue, which opened for bidding on January 29, closed on January 31, with a price band set between the range of Rs 382 to Rs 402 per share.

The allotment status is likely to be finalised on today, February 3. Those who get allotted shares will see them credited to their demat accounts before the listing date. Dr Agarwals Healthcare shares are set to list on both the BSE and NSE on February 5.

How to Check Dr Agarwals Healthcare IPO Allotment Status

Investors who applied for shares in Dr Agarwals Healthcare IPO can check the allotment status online through multiple platforms such as BSE, NSE or the registrar, KFin Technologies. Here’s the step by step guide to check the status:

– Via BSE

  • Go to BSE’s IPO allotment page: BSE IPO Status
  • Select ‘Equity’ as the issue type
  • Choose ‘Dr Agarwal’s Healthcare Ltd’ from the IPO names list
  • Enter your PAN Number or Application Number
  • Click on ‘Submit’ to check if you have been allotted shares

Also ReadUpcoming IPOs this week: 5 new SME issues and 2 listings to watch – Via NSE

  • Visit NSE’s bid verification portal: NSE IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’
  • Enter your Application Number and PAN Number
  • Click on ‘Submit’ to view the status

– Via  KFin Technologies

  • Visit the IPO allotment status page: KFin Technologies IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’ from the IPO dropdown list
  • Enter your PAN, Application Number, DP ID, or Account Number
  • Fill in the required details for verification
  • Click on ‘Submit’ to check your allotment status

Dr Agarwal IPO: Subscription and GMP Trends

Dr Agarwals Healthcare IPO received a subscription of 1.49 times by the end of the bidding period. Breaking it down, QIBs portion saw a subscription rate of 4.41 times, NII portion was booked 0.39 times and the retail portion received a subscription rate of 0.42 times.

GMP: As per the latest GMP trends, the stock is trading at a Rs 1.5 premium, hinting at a listing price of around Rs 403.5 per share.

 » Read More

Related Articles

‘Some things just make more sense when…’: Joe Rogan cracks up at hilarious crypto video explaining price volatility

Famous American podcaster and comedian Joe Rogan has seen and heard a lot of crazy things on his podcast — from aliens to wild health experiments. But recently, something caught his attention in a way he didn’t expect—a funny video about crypto by comedian Masood Boomgard, also known as Self-Help Singh.  Boomgard’s video, posted on

Nuvama reaffirms Buy on Vedanta. 3 reasons why…

The brokerage firm Nuvama has reaffirmed its ‘Buy’ on Vedanta, maintaining a target price of Rs 663 based on FY27E sum-of-the-parts valuation. According to brokerage firm, the growth prospects for Vedanta remain intact, defined by it positive performance across multiple segments. 3 reasons why the firm continues to rate the stock as a ‘Buy’ –

HUDCO shares fall 12% as Budget disappoints on policy boost and capex

The share price of HUDCO fell 12% to an intra-day low of Rs 191.21 after the Union Budget 2025-26 disappointed investors due to a lack of specific policies for affordable housing and reduced capital expenditure.  The shares of HUDCO declined 5.4% during the special budget session as well. The capital expenditure has been reduced to

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

‘Some things just make more sense when…’: Joe Rogan cracks up at hilarious crypto video explaining price volatility

Famous American podcaster and comedian Joe Rogan has seen and heard a lot of crazy things on his podcast — from aliens to wild health experiments. But recently, something caught his attention in a way he didn’t expect—a funny video about crypto by comedian Masood Boomgard, also known as Self-Help Singh.  Boomgard’s video, posted on

Nuvama reaffirms Buy on Vedanta. 3 reasons why…

The brokerage firm Nuvama has reaffirmed its ‘Buy’ on Vedanta, maintaining a target price of Rs 663 based on FY27E sum-of-the-parts valuation. According to brokerage firm, the growth prospects for Vedanta remain intact, defined by it positive performance across multiple segments. 3 reasons why the firm continues to rate the stock as a ‘Buy’ –

HUDCO shares fall 12% as Budget disappoints on policy boost and capex

The share price of HUDCO fell 12% to an intra-day low of Rs 191.21 after the Union Budget 2025-26 disappointed investors due to a lack of specific policies for affordable housing and reduced capital expenditure.  The shares of HUDCO declined 5.4% during the special budget session as well. The capital expenditure has been reduced to

What Homebuyers Gained from Budget 2025 – More savings, tax perks & more

The Union Budget 2025 has emerged as a game-changer for homebuyers, offering multiple tax benefits and incentives. From easing taxation policies to boosting affordable housing, the government’s initiatives are set to have a lasting impact on the real estate sector and homebuyers. Be it tax reforms under the new tax regime or exempting second property

Markets close lower: Nifty below 23,400, Sensex slides over 300 points; L&T, Tata Motors among losers

Equity markets slipped into negative territory on Monday, with key indices closing lower. The BSE Sensex ended the session in red, shedding 319.22 points or 0.41%, to settle at 77,186.74. Meanwhile, the NSE Nifty 50 declined by 121.10 points, a 0.52% drop, closing at 23,361.05. The Nifty Bank index also faced selling pressure, closing at